Literature DB >> 15243580

Erythropoietin as an antiapoptotic, tissue-protective cytokine.

P Ghezzi1, M Brines.   

Abstract

Erythropoietin (EPO) increases the number of circulating erythrocytes primarily by preventing apoptosis of erythroid progenitors. In addition to this proerythroid action, results of recent studies show that systemically administered EPO is protective in vivo, in several animal models of neuronal injury. In vitro, EPO prevents neuronal apoptosis induced by a variety of stimuli. This review summarizes the neuroprotective actions of EPO and discusses the underlying mechanisms in terms of signal transduction pathways involved. The understanding of these mechanisms will help differentiate the neuroprotective actions of EPO from its role in the bone marrow.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15243580     DOI: 10.1038/sj.cdd.4401450

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  98 in total

1.  Extended and stable gene expression via nucleofection of MIDGE construct into adult human marrow mesenchymal stromal cells.

Authors:  P L Mok; S K Cheong; C F Leong; K H Chua; O Ainoon
Journal:  Cytotechnology       Date:  2011-12-10       Impact factor: 2.058

2.  Effect of recombinant erythropoietin on ischemia-reperfusion-induced apoptosis in rat liver.

Authors:  Heba M Shawky; Sandra M Younan; Leila A Rashed; Heba Shoukry
Journal:  J Physiol Biochem       Date:  2011-09-28       Impact factor: 4.158

3.  Cerebral tissue repair and atrophy after embolic stroke in rat: a magnetic resonance imaging study of erythropoietin therapy.

Authors:  Guangliang Ding; Quan Jiang; Lian Li; Li Zhang; Ying Wang; Zheng Gang Zhang; Mei Lu; Swayamprava Panda; Qingjiang Li; James R Ewing; Michael Chopp
Journal:  J Neurosci Res       Date:  2010-11-01       Impact factor: 4.164

4.  Erythropoietin-induced changes in brain gene expression reveal induction of synaptic plasticity genes in experimental stroke.

Authors:  Manuela Mengozzi; Ilaria Cervellini; Pia Villa; Zübeyde Erbayraktar; Necati Gökmen; Osman Yilmaz; Serhat Erbayraktar; Mathini Manohasandra; Paul Van Hummelen; Peter Vandenabeele; Yuti Chernajovsky; Alexander Annenkov; Pietro Ghezzi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-29       Impact factor: 11.205

Review 5.  The therapeutic potential of insulin-like growth factor-1 in central nervous system disorders.

Authors:  Jesse Costales; Alexander Kolevzon
Journal:  Neurosci Biobehav Rev       Date:  2016-01-15       Impact factor: 8.989

6.  Oncolytic Poxviruses.

Authors:  Winnie M Chan; Grant McFadden
Journal:  Annu Rev Virol       Date:  2014-09-01       Impact factor: 10.431

7.  Nitric oxide synthase mediates the ability of darbepoetin alpha to improve the cognitive performance of STOP null mice.

Authors:  Kosuke Kajitani; Michael Thorne; Michel Samson; George S Robertson
Journal:  Neuropsychopharmacology       Date:  2010-03-24       Impact factor: 7.853

8.  Otoprotective effects of erythropoietin on Cdh23erl/erl mice.

Authors:  F Han; H Yu; T Zheng; X Ma; X Zhao; P Li; L Le; Y Su; Q Y Zheng
Journal:  Neuroscience       Date:  2013-02-04       Impact factor: 3.590

9.  Evaluation of the therapeutic benefit of delayed administration of erythropoietin following early hypoxic-ischemic injury in rodents.

Authors:  M L Alexander; C A Hill; T S Rosenkrantz; R H Fitch
Journal:  Dev Neurosci       Date:  2013-01-10       Impact factor: 2.984

Review 10.  Predictors of response to erythropoiesis-stimulating agents (ESA) in cancer patients: the role of baseline serum epoetin level.

Authors:  Jaime Sanz Ortiz
Journal:  Clin Transl Oncol       Date:  2008-08       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.